Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
111 hedge funds and large institutions have $635M invested in Momenta Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 111 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
124% more call options, than puts
Call options by funds: $10.5M | Put options by funds: $4.69M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RNS
101
Robert N. Shapiro
| $27K | +$23.9K | +1,813 | New |
|
|
RFC
102
Russell Frank Company
Seattle,
Washington
| $23K | +$19.8K | +1,502 | New |
|
103
BlackRock
New York
| $22K | +$19.8K | +1,501 | New |
|
|
GT
104
Glenmede Trust
Philadelphia,
Pennsylvania
| $21K | +$18.8K | +1,425 | New |
|
|
TRCT
105
Tower Research Capital (TRC)
New York
| $18K | +$16.1K | +1,223 | New |
|
106
Bank of Montreal
Toronto,
Ontario, Canada
| $13K | +$11.6K | +879 | New |
|
|
OA
107
OFI Advisors
Philadelphia,
Pennsylvania
| $13K | +$11.6K | +880 | New |
|
|
OMCS
108
Old Mutual Customised Solutions
Pinelands,
South Africa
| $9K | +$7.92K | +600 | New |
|
109
Wells Fargo
San Francisco,
California
| $5K | +$3.96K | +300 | New |
|
|
ST
110
Spot Trading
Chicago,
Illinois
| $2K | +$1.4K | +106 | New |
|
111
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| $252 | +$220K | +16,700 | New |
|
MNTA Hedge Fund Activity: Q2 2013 in Review
111 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q2 2013, worth a combined $635M.
Buyers outnumbered sellers: 111 funds opened new MNTA positions and 0 closed out — a net gain of 111 holders — while 0 added to existing stakes and 0 trimmed.
- 111 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $635M of Momenta Pharmaceuticals, Inc. stock for Q2 2013.
- 111 funds opened new Momenta Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +111 holders.
Based on aggregated 13F filings for Q2 2013.